Gyokai Digest home
Mitsubishi Chemical
Mitsubishi Chemical
Q1 FY2027 (Apr-Jun 2026)

Mitsubishi Chemical Q1 FY2027: Core operating profit doubles, lifts H1 outlook

Mitsubishi Chemical
earnings
earnings analysis
quarterly results
revenue and profit growth
upward revision
semiconductors
industrial gases
inventory valuation gains
medium-term management plan
Q1 cumulativeFirst 3 months of the fiscal year, year-over-year

Revenue

¥1.0T

+14.0%

Full-year forecast

¥3.8T

Progress26%

Operating Profit

¥118.4B

+94.4%

Full-year forecast

¥300.0B

Progress39%

Net Income

¥57.7B

+194.0%

Full-year forecast

¥127.0B

Progress45%

Operating Margin

11.8%

Mitsubishi Chemical posted stellar Q1 FY2027 results, with revenue up 14.0% to ¥1,004.2 billion, core operating profit more than doubling to ¥114.1 billion, and net income surging 194.0% to ¥57.7 billion. Gains were driven by semiconductor demand, higher MMA prices, and inventory valuation profits from rising naphtha, leading the company to lift its first-half outlook.

Performance Highlights

Mitsubishi Chemical delivered sharp profit growth in the first quarter of fiscal 2027, with all key earnings lines improving substantially. Revenue reached ¥1,004,246 million (+14.0% YoY), core operating profit ¥114,104 million (+101.7%), operating profit ¥118,400 million (+94.4%), pre-tax profit ¥111,806 million (+122.9%), and net income attributable to owners of the parent ¥57,706 million (+194.0%), rebounding strongly from the year-earlier dip.

Main drivers included: 1) expanding demand for high-performance engineering plastics used in semiconductor manufacturing equipment and carbon fiber composites for robotaxis, lifting Specialty Materials; 2) higher MMA monomer market prices; 3) inventory valuation gains triggered by a surge in naphtha prices amid heightened Middle East tensions; and 4) the tailwind from a weaker yen. At the operating profit level, a ¥12,815 million gain on the sale of tangible fixed assets also provided a boost.

Reflecting the strong Q1, the company raised its cumulative first-half (interim) forecasts: revenue to ¥2,043.0 billion (from ¥1,861.0 billion) and core operating profit to ¥194.0 billion (from ¥139.0 billion), a significant upward revision from initial plans.

Segment Trends

The company reorganized its reporting segments from this quarter into four categories: Specialty Materials, MMA & Derivatives, Basic Materials, and Industrial Gases. All segments posted higher revenue and profits or returned to profitability, with Specialty Materials and Industrial Gases the main profit drivers.

SegmentRevenue (¥M)YoY ChangeCore Op Profit (¥M)YoY ChangeMargin
Specialty Materials332,538+16.3%38,340+120.6%11.5%
MMA & Derivatives99,927+11.5%8,008+119.1%8.0%
Basic Materials185,041+11.8%14,814turned profitable8.0%
Industrial Gases359,995+15.0%54,079+20.1%15.0%
Others26,745+0.4%315+12.5%1.2%

Specialty Materials saw robust demand for high-performance materials in semiconductor equipment, plus increased sales volumes of carbon fiber composite parts for robotaxis and barrier packaging films. Improved sales mix and cost reductions also contributed.

MMA & Derivatives achieved profit growth despite some supply-chain disruptions linked to Middle East instability, benefiting from higher MMA monomer prices and improved selling prices across products.

Basic Materials swung to a large profit from a loss a year earlier, as inventory valuation gains from rising naphtha prices more than offset narrower margins on polyolefins. While scheduled maintenance at ethylene centers and lower sales volumes weighed, higher feedstock costs were passed through to selling prices.

Industrial Gases delivered steady growth, supported by disciplined price management across all regions and the prior year’s acquisitions in Australia and New Zealand. Higher US power costs squeezed margins, but cost savings and a weaker yen kept the segment’s profit up, underscoring its earnings stability.

SegmentRevenueShareOp. ProfitOp. Margin
Specialty Materials¥332.5B33%¥38.3B11.5%
MMA & Derivatives¥99.9B10%¥8.0B8.0%
Basic Materials¥185.0B18%¥14.8B8.0%
Industrial Gases¥360.0B36%¥54.1B15.0%
Others¥26.7B3%¥315M1.2%

Financial Position and Capital Policy

Total assets at quarter-end stood at ¥5,881,036 million, up ¥4.4 billion from the previous fiscal year-end, largely due to a weaker yen inflating the translated value of overseas subsidiaries and higher inventory values from rising raw material costs. The equity attributable to owners of the parent ratio improved to 31.0% (from 30.0%). The company continued to repay interest-bearing debt and redeem bonds (¥30.0 billion), maintaining adequate liquidity.

Operating cash flow was ¥35,067 million (down 41.8% YoY), pressured by higher inventories and a decrease in trade payables. Investing cash flow was negative ¥26,349 million, reflecting capital expenditures and asset sales, while financing cash flow was negative ¥93,390 million due to loan repayments and dividends. Cash and cash equivalents ended at ¥445,086 million (down ¥82,018 million from the previous year-end).

The annual dividend is planned at ¥32.00 per share, unchanged from the previous year. No share buybacks were executed during the quarter; shareholder returns remain centered on stable dividends.

Risks and Challenges

The earnings report highlights several key risks and challenges:

  • Middle East uncertainty: Ongoing risks of raw material procurement and logistics disruptions, plus volatile naphtha prices that could swing inventory valuation gains to losses.
  • Global economic downside: Concerns about a slowing Chinese economy, weak European activity, and protracted inflation dampening demand.
  • Foreign exchange volatility: While a sharply weaker yen benefits earnings, a rapid yen appreciation would pressure revenue and profit.
  • Intensifying competition: Growing demand for high-performance materials such as semiconductor-related products is expected, but technology and price competition could heat up.
  • Business restructuring execution risk: The separation of Tanabe Pharma and post-reorganization integration benefits may not materialize as planned.

Full-Year Outlook

Buoyed by the strong Q1, Mitsubishi Chemical raised its first-half (interim) forecasts, but kept full-year consolidated guidance unchanged given high uncertainty in the second half. The revision was mainly driven by stronger chemical demand and larger-than-expected inventory valuation gains.

Item (¥100M)Previous Forecast (A)Revised (B)ChangeFY2026 Actual
Revenue1,861.02,043.0+9.8%1,799.1
Core Operating Profit139.0194.0+39.6%126.1
Operating Profit143.0189.0+32.2%86.5
Net Income Attrib. to Parent59.086.0+45.8%110.1

Full-year forecasts remain at: revenue ¥3,800.0 billion, core operating profit ¥305.0 billion, operating profit ¥300.0 billion, and net income attributable to owners of the parent ¥127.0 billion. Management maintained a cautious stance, noting that naphtha price volatility tied to Middle East conditions could cause inventory valuation gains to reverse in the second half.

Analyst take

Q1 was extremely strong on paper, thanks to a combination of structural demand growth in semiconductor materials and composites, plus a one-off boost from naphtha-driven inventory valuation gains. While the solid earnings power of Industrial Gases and the portfolio shift toward Specialty Materials are encouraging, sustainable growth will require organic profit expansion beyond these temporary factors. Management’s decision to leave full-year guidance unchanged reflects precisely that uncertainty.

Read this report in Japanese